Free Market Research Guides to Download

Biotechnology Analysis & Statistics in China, October 2012 (p2)

You might be interested in: biotech, biomedical, biomaterials, more »

» Purchase Premium Reports

31-60 of about 100 reports
Chinese Markets for Dental Bone Grafts and Other Biomaterials - Executive Summary

Chinese Markets for Dental Bone Grafts and Other Biomaterials - Executive Summary

  • $ 295
  • Industry report
  • October 2012
  • by iData Research, Inc.

Scope: This report pertains to a forecast period of 10 years (2008 - 2018) for China. Report Contents: Competitor Analysis Identified Strategic Opportunities Market Overview by Segment & Country Trend ...

  • Industries : Biomaterial
  • Countries : China
Biomaterials China News 1209 - Annual subscription

Biomaterials China News 1209 - Annual subscription

  • $ 2 511
  • Industry report
  • September 2012
  • by CCM International Limited

Nationally depressing economy is going on in early Sept. 2012. According to the statistic data excluding finance industry, the operating income of China's A-share companies increased by about 7.8% in H1 ...

  • Industries : Biomaterial
  • Countries : China
Erythropoietin (EPO) Market Report: 2012 Edition

Erythropoietin (EPO) Market Report: 2012 Edition

  • $ 850
  • Industry report
  • September 2012
  • by Koncept Analytics

With the advent of novel technology, companies operating in the healthcare/science/pharmaceutical/therapeutic area are now scaling new heights. Also this industry is boosted by the rising number of incidences ...

  • Industries : Biopharmaceutical
  • Countries : Japan, China
Huifeng BioPharmaceutical Technology Inc. (HFGB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Huifeng BioPharmaceutical Technology Inc. (HFGB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2012
  • by Global Data

Huifeng BioPharmaceutical Technology Inc. (HFGB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Huifeng BioPharmaceutical Technology Inc. (Huifeng) is a biopharmaceutical company, ...

  • Industries : Biopharmaceutical
  • Countries : China
Biotechnology Market Overview in China

Biotechnology Market Overview in China

  • $ 350
  • Industry report
  • August 2012
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Biopharmaceutical
  • Countries : China
Liver Failure - Pipeline Review, H2 2012

Liver Failure - Pipeline Review, H2 2012

  • $ 500
  • Company report
  • July 2012
  • by Global Markets Direct

Liver Failure - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Liver Failure - Pipeline Review, H2 2012', provides an overview of the Liver Failure therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World, Spain, China
Biomaterials China News 1207

Biomaterials China News 1207

  • $ 2 511
  • Industry report
  • July 2012
  • by CCM International Limited

The global economic shrinking is going on. In June 2012, the US and German's PMI decreased to the lowest point during the past three years, and China's PMI has been below 50 (the separation of manufacture ...

  • Industries : Biomaterial
  • Countries : China
Chinese Biotechnology Sector: Sector Report

Chinese Biotechnology Sector: Sector Report

  • $ 800
  • Industry report
  • July 2012
  • by Daedal Research

This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics ...

  • Industries : Biotechnology
  • Countries : China
China Genetic Engineering Drug Industry Report, 2011-2012

China Genetic Engineering Drug Industry Report, 2011-2012

  • $ 1 900
  • Industry report
  • July 2012
  • by Research In China

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs. ...

  • Industries : Biopharmaceutical
  • Countries : China
Biomaterials China News 1206 - Annual Subscription

Biomaterials China News 1206 - Annual Subscription

  • $ 2 511
  • Industry report
  • June 2012
  • by CCM International Limited

When it enters May 2012, global economic environment becomes more complex. Some European countries will face the general election. Greek debt crisis is escalating; whether it can continue to stay in the ...

  • Industries : Biomaterial
  • Countries : China
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: NeoStem, Inc. (NBS)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: NeoStem, Inc. (NBS)

  • $ 250
  • Company report
  • June 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States, China
Chinese Biotechnology Market Research

Chinese Biotechnology Market Research

  • $ 600
  • Industry report
  • June 2012
  • by Koncept Analytics

This market profile helps to gain an insight into the evolution of the market and competitive dynamics prevalent in the industry . It discusses the significant developments in the market and analyzes the ...

  • Industries : Biotechnology
  • Countries : China
Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth

Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth Summary GBI Research, a leading business intelligence provider, has released its latest research ?Biological ...

  • Industries : Biopharmaceutical
  • Countries : Russian Federation, China, Brazil, India, World
China Biological & Biochemical Products Industry Profile

China Biological & Biochemical Products Industry Profile

  • $ 580
  • Industry report
  • May 2012
  • by Beijing Zeefer Consulting Ltd

Through a comparative analysis on the development of biological & biochemical products industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data ...

  • Industries : Biotechnology
  • Countries : China
Biomaterials China News 1205

Biomaterials China News 1205

  • $ 2 511
  • Industry report
  • May 2012
  • by CCM International Limited

As the Welsh government enforced the customers to pay the 5p tax on plastic bags since Oct. 2011, Welsh supermarket has given a 90% off for plastic bags recently. Now the Scottish government plans to follow ...

  • Industries : Biomaterial
  • Countries : China
Company Study of Walvax Biotechnology Co, Ltd.,2012

Company Study of Walvax Biotechnology Co, Ltd.,2012

  • $ 329
  • Company report
  • May 2012
  • by Research In China

Walvax Biotechnology Co, Ltd. (Walvax Biotechnology for short), founded in 2001, specializes in research & development, production and marketing of bio-pharmaceutical vaccines. In September 2010, it went ...

  • Industries : Biotechnology
  • Countries : China
Biopharmaceutical: Calypte Biomedical Corporation (CBMC)

Biopharmaceutical: Calypte Biomedical Corporation (CBMC)

  • $ 750
  • Company report
  • April 2012
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Calypte Biomedical Corporation portfolio of new product development . The report provides detailed analysis on each pipeline ...

  • Industries : Biopharmaceutical
  • Countries : United States, Thailand, China
Chenguang Biotech Group Co Ltd: Ingredients Company Profile, SWOT & Financial Report

Chenguang Biotech Group Co Ltd: Ingredients Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • April 2012
  • by Canadean Ltd

Synopsis Canadean's "Chenguang Biotech Group Co Ltd: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Biotechnology, Agriculture
  • Countries : China
Biomaterials China News 1204 - Annual Subscription

Biomaterials China News 1204 - Annual Subscription

  • $ 2 511
  • Industry report
  • April 2012
  • by CCM International Limited

BDO capacity will increase rapidly in China due to its strong demand from domestic downstream products,the industry policy support, and the application of its mainstream production technology. ...

  • Industries : Biomaterial
  • Countries : China
Eternal Technologies Group, Inc. (Symbol:ETLT) SWOT Analysis, Strategy, Revenues and Profits

Eternal Technologies Group, Inc. (Symbol:ETLT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : China
China Biopharma, Inc. (Symbol:CHBO) SWOT Analysis, Strategy, Revenues and Profits

China Biopharma, Inc. (Symbol:CHBO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : China
China Dasheng Biotechnology Co (Symbol:CDBT) SWOT Analysis, Strategy, Revenues and Profits

China Dasheng Biotechnology Co (Symbol:CDBT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : China
Sinobiomed, Inc. (Symbol:SOBM) SWOT Analysis, Strategy, Revenues and Profits

Sinobiomed, Inc. (Symbol:SOBM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : China
Top Three Companies In Biological & Biochemical Products Mfg. Industry In China

Top Three Companies In Biological & Biochemical Products Mfg. Industry In China

  • $ 150
  • Industry report
  • March 2012
  • by Beijing Zeefer Consulting Ltd

This report provides company profiles and financial data of the top 3 companies in biological & biochemical products mfg. industry in China. The content includes profit & loss sheet, balance sheet, key ...

  • Industries : Biotechnology
  • Countries : China
Changmao Biochemical Engineering Co., Lt: Ingredients Company Profile, SWOT & Financial Report

Changmao Biochemical Engineering Co., Lt: Ingredients Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • March 2012
  • by Canadean Ltd

Synopsis Canadean's "Changmao Biochemical Engineering Co., Lt: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Biotechnology
  • Countries : Australia, Japan, China
Biomaterials China News 1203 - Annual Subscription

Biomaterials China News 1203 - Annual Subscription

  • $ 2 511
  • Industry report
  • March 2012
  • by CCM International Limited

China announces to cut its GDP growth target to 7.5% in 2012, according to Premier Wen Jiabao's announcement in his government work report delivered to the National People's Congress on March 5th, 2012. ...

  • Industries : Biomaterial
  • Countries : China
Seed China News 1202 - Annual Subscription

Seed China News 1202 - Annual Subscription

  • $ 3 013
  • Industry report
  • February 2012
  • by CCM International Limited

Recently, the draft for Food Law made by National Development and Reform Commission (NDRC) and State Administration of Grain was released on the official website. Among the 97 provisions in the draft, ...

  • Industries : Horticulture, Biotechnology
  • Countries : China
Delving into Stem Cell Research and its Potential

Delving into Stem Cell Research and its Potential

  • $ 350
  • Industry report
  • January 2012
  • by Aruvian's R'search

Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. ...

  • Industries : Biological Therapy
  • Countries : World, Australia, United States, United Kingdom, Europe, Canada, Germany, Japan, Israel, China
Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

  • $ 3 500
  • Industry report
  • December 2011
  • by GBI Research

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment Summary GBI Research's report, ?Oncology Devices Market ...

  • Industries : Biological Therapy
  • Countries : World, Australia, Brazil, Canada, Spain, Italy, Germany, Japan, India, China, France, United States, United Kingdom, Europe, Oceania, Asia, South America, North America
Medigen Biotechnology Corp. (Symbol:3176) SWOT Analysis, Strategy, Revenues and Profits

Medigen Biotechnology Corp. (Symbol:3176) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • December 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : China

» Download Public Reports

About 200 reports
Tianjin TEDA Biomedical Engineering Company Ltd. - Annual Report 2012

Tianjin TEDA Biomedical Engineering Company Ltd. - Annual Report 2012

  • Company report
  • December 2012
  • 90 pages
  • by Market Research Publisher

... As a National new product By five ministries in china. Financial review for the year ended 31 december 2012, the total turnover of the group in the biological compound fertilizer segment and the health care ...


Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.